跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MultiHance - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
MultiHance
Approved
STANDARD
MultiHance
Patheon Italia S.p.A.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1d65adcbfe290feb
Company
Patheon Italia S.p.A.
Type
Standard
Approval Details
Approval Id
1d65adcbfe290feb
Drug Approval Philippines Name
MultiHance
Product Name
MultiHance
Registration Number
DR-XY36359
Brand Name
MultiHance
Generic Name
Gadobenate dimeglumine
Dosage Form
Solution For IV Injection
Dosage Strength
529mg/mL (equivalent to Gadobenic acid 334 mg + Meglumine 195 mg/mL)
Manufacturer
Patheon Italia S.p.A.
Importer
New Marketlink Pharmaceutical Corporation
Distributor
Metro Drug, Inc.
Company Detail Path
/organization/patheon-italia-spa
Issuance Date
25 July 2024
Expiry Date
29 July 2029
Pharmacologic Category
Diagnostic agent
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1d65adcbfe290feb
Type
Standard
Back to Philippines FDA Approvals